Benjamin Rotz

Benjamin Rotz

Company: Eli Lilly & Co.

Job title: Associate Vice President, Global Medical Policy Strategy & Operations


Better Understanding the Approach Towards Post-Trial Access 10:30 am

As these programs are expensive to set up and operate, there is a risk to your company if the drug isn’t commercialized. An exit strategy must be clearly defined. Attend this discussion for answers on the following: • What are the options when ending a program in a country where the drugs won’t be commercialized?…Read more

day: Pre-Conference Day Track B 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.